Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

5 ArticlesSUNPHARMA

1 / 1

Exclusive: We Reveal The Observations Made By US FDA’s Inspection Of Sun Pharma’s Halol Facility

True to our promise of keeping a tab on the US FDAs inspection of Sun Pharma’s Halol facility, we are happy to get our hands on the Form 483 issued for ...
US-FDA-Sun-Pharma-Halol-Form-483-2.png

Tracking The Sun Pharma Halol Plant US FDA Inspection

This is not a recommendation to buy or sell the stock. Analyst and family do own some of the positions listed here. Please assume we are biased. With ...
Sun-Pharma-Share-Price-9-December.png

Sun Pharma Acquires Ocular Technologies and Launches Authorized Generic (AG) Versions of 4 Tablets

Sun Pharma – the world’s fifth largest specialty generic pharmaceutical company and India’s top pharmaceutical company providing medicines to ...
Sun-Pharma-Share-Price-27-October-2016.png

Exclusive: Sun Pharmaceutical Industries recalls 16,085 bottles of antidepressant tablets

Drug major Sun Pharmaceutical Industries Inc. (the US subsidiary of Sun Pharma), initiated a recall of antidepressant medication used to treat major depressive ...
47335-737-88_buPropionHCI_ER_USPSR_150mg_100ct.jpg

Premium: US FDA Warning Letter to Sun Pharmaceutical Industries for Halol facility

  On the 17-Dec-15 (Thursday), the US FDA issued a Warning Letter to Sun Pharmaceuticals. The letter was in relation to the inspection performed from ...